Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.

Precision Neuroscience Corp., a brain implant rival to Elon Musk’s Neuralink Corp., has raised $93 million of a planned $100 ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.

Synchron CEO Tom Oxley hopes Donald Trump will revive a proposed a new rule – which Joe Biden pulled back – to get ...

Neuralink’s device went into its first human patient as part of a trial earlier this year. And a team at the University of California, Davis, implanted an ALS patient with a device that allowed ...

In September, Neuralink received a "breakthrough device ... It's likely years away from completing a clinical trial, however. More substantively, Science Corp's latest clinical trial, the findings ...

S cience Corporation, a rival to Elon Musk’s Neuralink in the development of brain-computer interface (BCI) technology, has just unveiled promising early clinical trial results for an eye implant that ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its ...

A team of researchers designed a eye implant that has enabled legally blind patients to read again, sparking new competition with Neuralink.